Synairgen plc (AIM: SNG)
London
· Delayed Price · Currency is GBP · Price in GBX
4.489
-0.131 (-2.84%)
Nov 19, 2024, 10:21 AM GMT+1
Synairgen Statistics
Total Valuation
Synairgen has a market cap or net worth of GBP 9.24 million. The enterprise value is 652,111.
Market Cap | 9.24M |
Enterprise Value | 652,111 |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
Earnings Date | Dec 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Synairgen has 201.37 million shares outstanding. The number of shares has increased by 0.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 201.37M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | 2.08% |
Owned by Institutions (%) | 25.67% |
Float | 140.08M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.97 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.09 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.10 |
Financial Position
The company has a current ratio of 9.76
Current Ratio | 9.76 |
Quick Ratio | 9.76 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.24% and return on invested capital (ROIC) is -42.53%.
Return on Equity (ROE) | -54.24% |
Return on Assets (ROA) | -36.99% |
Return on Capital (ROIC) | -42.53% |
Revenue Per Employee | n/a |
Profits Per Employee | -192,306 |
Employee Count | 36 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.64% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -29.64% |
50-Day Moving Average | 4.30 |
200-Day Moving Average | 5.04 |
Relative Strength Index (RSI) | 47.38 |
Average Volume (20 Days) | 180,790 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.69M |
Pretax Income | -8.11M |
Net Income | -6.92M |
EBITDA | -8.64M |
EBIT | -8.69M |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Cash & Cash Equivalents | 8.59M |
Total Debt | n/a |
Net Cash | 8.59M |
Net Cash Per Share | 0.04 |
Equity (Book Value) | 9.56M |
Book Value Per Share | 0.05 |
Working Capital | 9.45M |
Cash Flow
In the last 12 months, operating cash flow was -6.61 million and capital expenditures -12,000, giving a free cash flow of -6.62 million.
Operating Cash Flow | -6.61M |
Capital Expenditures | -12,000 |
Free Cash Flow | -6.62M |
FCF Per Share | -0.03 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Synairgen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | -0.01% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |